Ampriondx
1 known investors
Amprion develops SAAmplify®-αSYN, a diagnostic test that detects pathological α-synuclein in cerebrospinal fluid to improve diagnosis of neurodegenerative diseases like Parkinson's, Lewy body dementia, and Alzheimer's. The test is used by physicians to guide treatment decisions based on biological evidence rather than symptom-based diagnosis.
Digital HealthMedical Devices